Mintz Attorney Dionne Lomax to Present at American Health Lawyers Association’s Physicians and Hospitals Law Institute
Dionne Lomax, a Member of the Antitrust Section of Mintz, Cohn, Ferris, Glovsky and Popeo, P.C., is speaking at the Physicians and Hospitals Law Institute presented by the American Health Lawyers Association (AHLA). The conference is taking place February 8-10 at the Hilton in Austin, Texas.
Ms. Lomax’s presentation is entitled, “The Antitrust Treatment of Provider Mergers and Affiliations in a Post-ACA World.” This session will cover recent antitrust enforcement actions against health care providers by the Federal Trade Commission (“FTC, Department of Justice (“DOJ”) and State Attorneys General and offer practical advice for entities contemplating a joint venture, merger, or similar transaction with a competing provider, including tips on how to successfully navigate an antitrust investigation.
The 2016 Physicians and Hospitals Law Institute will feature a number of sessions focusing on the legal challenges faced by physicians and their counsel, the legal challenges faced by hospitals and health systems and their counsel, and the legal issues of interest to both segments of the health care delivery system.
Ms. Lomax’s antitrust and trade regulation practice includes counseling and representation in connection with merger and non-merger related activities, litigation, and matters before the DOJ and the FTC. She has been involved in antitrust matters spanning a broad range of industries, but as a former DOJ Antitrust Division Trial Attorney (in the Health Care Task Force Section), has particularly deep experience in the health care industry. Ms. Lomax has represented large health systems, major medical associations, large multispecialty physician groups, pharmaceutical companies, and medical device manufacturers in connection with mergers and acquisitions, joint ventures, and other commercial arrangements. She has counseled various clients in responding to antitrust investigations conducted by the DOJ, FTC, and various state antitrust agencies.